Lisa DiFrancisco
SVP, Investor Relations and Corporate Communications, Lexicon Pharmaceuticals
Replay available
Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2025 Earnings Call
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Mike Exson
Chief Executive Officer and Director, Lexicon Pharmaceuticals
Dr. Craig Granowitz
Senior Vice President and Chief Medical Officer, Lexicon Pharmaceuticals
Scott Chianti
Senior Vice President and Chief Financial Officer, Lexicon Pharmaceuticals
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Lexicon Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:05.180 Welcome to the Lexicon Pharmaceuticals' Second Quarter 2025 Financial 00:00:05.180 -- 00:00:09.940 Results Conference Call. At this time, all participants are in a listen-only mode. 00:00:09.940 -- 00:00:14.540 Following management's prepared remarks, we will hold a brief -and-answer session. 00:00:14.540 -- 00:00:19.920 As a reminder, this call is being recorded today, August 6, 2025. 00:00:19.920 -- 00:00:23.680 I will now turn the call over to Lisa DiFrancisco, 00:00:23.680 -- 00:00:27.680 SVP Investor Relations and Corporate Communications for Lexicon. 00:00:27.680 -- 00:00:30.140 Please go ahead, Lisa. 00:00:30.140 -- 00:00:35.360 Thank you, Josh. Good morning and welcome to our Second Quarter 2025 Conference Call. 00:00:35.360 -- 00:00:40.080 Joining me today are Dr. Mike Exson, Lexicon's Chief Executive Officer and Director, 00:00:40.080 -- 00:00:45.100 Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Chianti, 00:00:45.100 -- 00:00:47.760 Senior Vice President and Chief Financial Officer. 00:00:47.760 -- 00:00:51.520 This morning, Lexicon issued a press release announcing our financial results for the 00:00:51.520 -- 00:00:56.680 second quarter of 2025, which is available on our website at .lexpharma.com 00:00:56.780 -- 00:01:01.140 and through our SEC filing. A webcast of this call, along with a slide presentation, 00:01:01.140 -- 00:01:04.860 is also available on our website. During this call, we will review the information provided 00:01:04.860 -- 00:01:08.460 in the press release, provide a corporate update, then use the remainder of our time 00:01:08.460 -- 00:01:12.660 to answer your questions. Before we begin, let me remind you that we will be making forward-looking 00:01:12.660 -- 00:01...